Understanding Your CNS Tumor: Precision Genetic Testing for Better Outcomes
When facing a central nervous system tumor diagnosis, the uncertainty can feel overwhelming. You deserve clear answers and a personalized treatment path. Our Cancer Targeted Gene Panel CNS Tumor Test provides the genetic insights needed to make informed decisions about your care journey.
What This Test Reveals About Your CNS Tumor
This comprehensive genetic analysis examines 9 critical biomarkers that directly influence treatment decisions and prognosis for brain and spinal cord tumors. Using advanced Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), and Fluorescence In Situ Hybridization (FISH) technologies, we provide precise genetic profiling that helps your oncologist tailor your treatment plan.
Key Genetic Markers Analysed:
- IDH1 & IDH2 mutations – Critical for glioma classification and prognosis
- EGFR amplification – Influences targeted therapy options
- 1p19q codeletion – Essential for oligodendroglioma diagnosis
- BRAF mutations – Opens targeted treatment possibilities
- TP53 and ATRX – Important for tumor behavior assessment
- PTEN and Ki67 – Key indicators of tumor growth patterns
Who Should Consider This Genetic Testing?
This test is particularly valuable if you’re experiencing:
- Recent diagnosis of brain tumor or CNS malignancy
- Uncertainty about the most effective treatment approach
- Family history of brain cancers or genetic syndromes
- Need for clarity on tumor classification and behavior
- Considering targeted therapy or clinical trial options
- Recurrent tumors requiring updated genetic profiling
Early genetic characterization can significantly impact treatment success and quality of life outcomes.
Why Genetic Profiling Matters for Your Treatment Journey
Understanding your tumor’s genetic makeup transforms uncertainty into actionable information:
- Personalized Treatment Plans: Match your specific tumor genetics with the most effective therapies
- Prognostic Clarity: Understand your tumor’s likely behavior and progression patterns
- Targeted Therapy Access: Identify eligibility for precision medicines and clinical trials
- Reduced Treatment Guesswork: Move beyond one-size-fits-all approaches
- Peace of Mind: Make confident decisions based on comprehensive genetic data
Understanding Your Test Results
Your comprehensive report will provide clear, actionable information about each genetic marker analysed. Our medical team ensures results are presented in understandable language, with guidance on what each finding means for your treatment options. We’ll help you understand:
- Specific genetic alterations detected in your tumor
- How these findings influence treatment recommendations
- Potential targeted therapy options based on your results
- Prognostic implications of your genetic profile
- Next steps for discussing results with your oncology team
Remember: Knowledge empowers better decisions and more personalized care.
Transparent Pricing – Exceptional Value
| Test Option | Price | Savings |
|---|---|---|
| Special Offer Price | ZAR 9,000 | ZAR 2,700 savings |
| Regular Price | ZAR 11,700 | – |
Turnaround Time: Sample submitted Tuesday by 9 AM | Results in 10 working days
Sample Requirements: Formalin fixed paraffin embedded tissue block with completed NGS Test Requisition Form (Form 40)
Why Trust Oracle Genomics?
- Nationwide Coverage: Accessible testing across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise: Tests supervised by specialist oncologists and genetic experts
- Advanced Technology: Cutting-edge NGS, IHC, and FISH methodologies for maximum accuracy
- Proven Reliability: Trusted by healthcare professionals nationwide
- Patient-Centered Care: Compassionate support throughout your testing journey
Take Control of Your Treatment Journey Today
Don’t let uncertainty dictate your cancer care. Genetic insights can transform your treatment approach and outcomes. With our special pricing of ZAR 9,000, now is the time to gain the clarity you deserve.
Limited Time Special: Save ZAR 2,700 on comprehensive CNS tumor genetic profiling. Early detection and precise characterization can significantly impact treatment success.
Your journey to personalized cancer care starts with understanding your tumor’s genetic blueprint. Contact Oracle Genomics today and take the first step toward targeted, effective treatment.
